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Objective: This study was undertaken to identify factors that lead to improvements in the results of endovascular aneurysm
repair, with particular focus on new endograft design.
Methods: We analyzed data for patients enrolled in the European Collaborators on Stent Graft Techniques for Abdominal
Aortic Aneurysm Repair (EUROSTAR) registry, and compared those for endografts now withdrawn from the market
with those for endografts currently in use. Patients in whom a variety of endograft types were used in small numbers were
excluded. Postoperative and long-term outcomes were initially compared with univariate analyses, and subsequently
multivariate tests were used to adjust for baseline differences between the 2 groups. The main outcome measures were
freedom from a variety of secondary interventions, aneurysm rupture, and death.
Results: Some 1224 patients received “withdrawn” endografts, and 2768 patients received “current” endografts. The 2
groups were generally similar, but patients with current devices were more often men, significantly older, more frequently
unfit for open surgery, and had larger aneurysms with wider necks. Of no surprise, current endografts were also more
often used by experienced (>60 previous cases) surgical teams (44% vs 20%; P < .0001). Thirty-day clinical outcomes
were comparable in the 2 groups, although patients with withdrawn devices were less likely to have type II endoleak (9.2%
vs 5.5%; P < .0001), and those with current devices had a shorter mean hospital stay (5.4 vs 6.8 days; P < .0001). At 3
years more patients with current devices were free from secondary transfemoral intervention (88.4% vs 76%; P < .0001)
and conversion to open repair (95.4% vs 93.4%; P  .007). Aneurysm-related mortality at 3 years, defined as death due
to aneurysm rupture or within 30 days of a secondary intervention, was also less frequent with current endografts (2.7%
vs 4.4%; P  .02). Aneurysm rupture at 3 years was infrequent (0.8% vs 1.8%; P  .07). At multivariate analysis the use
of current devices was a protective factor against late conversion to open repair (hazard ratio, 0.49; 95% confidence
interval, 0.28-0.86; P  .014) and aneurysm-related death (hazard ratio, 0.51, 95% confidence interval, 0.34-0.75; P 
.0008). Larger aneurysm or neck diameter and shorter neck length were also associated with late conversion to open
repair; larger aneurysm diameter, older age, and unfitness for open surgery were predictive of aneurysm-related death.
Conclusion: Modern endograft design has improved the results of endovascular aneurysm repair. (J Vasc Surg 2004;40:
216-21.)Endovascular repair of abdominal aortic aneurysms has
been practiced for more than a decade.1 During this period
developments in technology based on clinical and experi-
mental experience have produced initially a range of “first-
generation,” commercially available endografts, and subse-
quently a number of “second-generation” devices, which
have gradually replaced conduits constructed in-house.
Furthermore, many first-generation devices have now been
withdrawn from the market after recognition of particular
faults during follow-up. It is not yet known whether such
improvements have resulted in better clinical outcomes.
While the results of randomized trials are awaited,
endovascular aneurysm repair remains under close scrutiny,
particularly now, with recent evidence that shows low mor-
tality after open aneurysm repair in selected cases.2 How-
ever, much of the criticism directed toward endovascular
aneurysm repair3 disregards the progressive improvements
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doi:10.1016/j.jvs.2004.04.017216in clinical results.4 Previous studies have identified variables
such as team experience and aneurysm or neck anatomy as
important indicators of long-term success.4-7 The purpose
of this study was to establish whether progress in endograft
design has resulted in better midterm clinical results inde-
pendent of such factors.
METHODS
The European Collaborators on Stent Graft Tech-
niques for Abdominal Aortic Aneurysm Repair (EURO-
STAR) registry8,9 is a voluntary registry that records data
on endovascular aneurysm repairs performed in Europe. To
the end of July 2003, data for 5466 aneurysm repairs
performed by 135 surgical teams had been collected. All
but the first 383 patients, who underwent surgery before
creation of the registry in July 1996, were entered prospec-
tively, and collaborators were required to register data at
least 24 hours before surgery to avert selection bias. The
database includes details of patient demographic data, co-
morbid conditions, aneurysm anatomy, operative interven-
tion, and postoperative outcome. Follow-up takes place 1,
3, 6, 12, and 18 months after surgery, and yearly thereafter.
Abnormalities detected on imaging studies during follow-
up, secondary interventions, complications, and deaths are
recorded.
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who underwent aneurysm repair with bifurcated devices
currently in use with data for patients who received bifur-
cated endografts now withdrawn from the market. Data for
patients in whom a variety of endografts were used in small
numbers were excluded from the analysis. We compared
baseline characteristics, and immediate and midterm out-
come in the 2 groups. Subsequently we attempted to
identify factors that independently influenced midterm re-
sults. The experience of the surgical team was also taken
into account; experienced centers were deemed to be those
in which at least 60 previous endovascular repairs had been
performed (approximately twice the mean experience of
EUROSTAR collaborators). The main outcome measures
were secondary intervention; conversion to open repair;
aneurysm rupture; and late aneurysm-related mortality,
defined as death due to aneurysm rupture or within 30 days
of a secondary intervention.
Statistical analysis. Univariate comparisons were
made with the Mann-Whitney U test for continuous vari-
ables and the 2 test, with a continuity correction for 2 2
tables, for categorical variables. Survival curves were esti-
mated with the life-table method, and were compared with
the log-rank test. Cox regression, with stepwise backward
elimination of unrelated factors, was used for multivariate
analyses, with independent variables chosen on the basis of
significant differences between the 2 groups at univariate
testing (P  .001). Statistical analysis was performed with
SAS software (SAS Institute).
RESULTS
We analyzed data for 3992 patients enrolled in
EUROSTAR between May 1994 and June 2002. Of these,
1224 patients received “withdrawn” devices and 2768
received “current” devices (Table I). Patients with current
devices were significantly older, were more frequently men,
and, although the 2 groups were comparable in terms of
comorbid factors, were more often unfit for open surgery
(Table II). Although neck and iliac artery angulation was
similar in the 2 groups, current devices were used to ex-
clude larger aneurysms with wider and shorter necks (Table
III). Some 206 patients (7.4%) with current devices had
aneurysm neck diameters in excess of 26 mm, and thus
would not have been suitable to receive a withdrawn en-
dograft. Of no surprise, current devices were used more
Table I. EUROSTAR devices
Current Withdrawn Period of use
AneuRx 857 0 12/1996 to date
EVT 55 51 6/1998 to date,
1/1995 to 5/1998
Excluder 337 0 1/98 to date
Stentor 0 277 5/94 to 9/98
Talent 739 0 10/96 to date
Vanguard 0 896 3/96 to date
Zenith 780 0 10/96 to date
Total 2768 1224frequently by experienced surgical teams (44% vs 20%; P
.0001).
Early outcome (30 days) was similar in the 2 groups.
Type II endoleak was more frequent with current en-
dografts (Table IV), but intraoperative conversion to open
repair occurred infrequently in both groups: 24 patients
(0.9%) in the current device group and 17 patients (1.4%)
in the withdrawn device group (P  .18). There was no
difference in postoperative mortality and morbidity, but
hospital stay was slightly shorter for patients with current
devices (Table V).
Table II. Patient demographic data and comorbid
conditions
Current
devices
(N  2768)
Withdrawn
devices
(N  1224)
Pn % n %
Age (y)
Mean 72 70 .0001
SD 7.9 7.7
Men 2606 94 1112 91 .0002
Smokers 657 24 300 24.5 .011
Diabetes 309 11 108 9 .32
Hypertension 1689 61 617 50 .17
Cardiac disease 1636 59 657 54 .3
Pulmonary disease 1136 41 409 33 .095
Renal disease 513 18.5 168 14 .03
Previous laparotomy 721 26 327 27 .7
Obesity 674 24 259 21 .03
ASA 2 1432 52 674 55 .056
Unfitness for open surgery 625 22.5 174 14 .0001
Missing data: smokers, 68 current, 167 withdrawn; diabetes, 59 current,
168 withdrawn; hypertension, 50 current, 158 withdrawn; cardiac disease,
48 current, 160 withdrawn; pulmonary disease, 79 current, 180 withdrawn;
renal disease, 107 current, 163 withdrawn; previous laparotomy and obesity,
3 current.
Table III. Aneurysm anatomy
Current
devices
(N  2768)
Withdrawn
devices
(N  1224)
Pn % n %
Neck angulation* 658 24 253 21 .12
Sac angulation* 327 12 118 10 .049
Right iliac angulation* 941 34 396 32 .32
Left iliac angulation* 1084 39 465 38 .32
Neck length (mm)
Mean 28 26.7 .0002
SD 11.2 11.7
Midneck diameter (mm)
Mean 24 22 .0001
SD 3 2.7
Aneurysm diameter (mm)
Mean 57 56
SD 10.8 10.5
Missing data: all variables: 3, current.
*Presence of significant angulation in the opinion of the collaborators, on
the basis of preoperative imaging studies.
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events occurred less frequently in patients with current
devices. These included occurrence of distal type I endoleak
(4.4% vs 12.9%; P  .0001), endograft limb thrombosis
(2.1% vs 9.8%; P  .0001), and need for a secondary
extra-anatomic bypass (1.2% vs 5%; P  .0001). There was
also a 2-fold reduction in secondary transfemoral interven-
tion (11.6% vs 24%; P  .0001; Fig 1), a 70% relative
reduction in conversion to open repair (4.6 vs 6.6, includ-
ing perioperative conversion; P  .007; Fig 2), and a 61%
relative reduction in the incidence of aneurysm-related
death (2.6% vs 4.4%; P  .02; Fig 3). Type I proximal
endoleak (6% vs 4.7%; P .66) and type III endoleak (7.3%
vs 8.4%; P  .44) occurred with similar frequency with
current and withdrawn devices. Freedom from late conver-
sion to open repair, excluding perioperative conversions,
was 95.6% with current devices and 95% with withdrawn
devices (P  .058). Aneurysm rupture was infrequent in
both groups; there were 7 events (0.8%) in patients with
current endografts and 15 events (1.8%) in those with
withdrawn endografts (P  .07). Overall survival was 86%
and 82.6% in current and withdrawn device groups, respec-
tively (P  .034).
Predictors of poor outcome during follow-up.
Multivariate analysis was performed on late conversion to
open repair and aneurysm-related death, because these
were the hardest end points potentially associated with
Table IV. Operative endoleaks
Current
devices
(N  2768)
Withdrawn
devices
(N  1224)
Pn % n %
Any 494 18 193 16 .12
Proximal 83 3 44 3.5 .37
Mid-graft 50 2 10 1 .026
Limb connection 33 1 13 1 .85
Type II 255 9 67 5.5 .0001
Internal iliac 17 0.5 7 0.5 1
Other 30 1 9 0.5 .39
Missing data: 0.
Table V. Postoperative outcome
Current
devices
(N 
2768)
Withdrawn
devices
(N 
1224)
Pn % n %
Systemic complications 376 13.5 169 14 .9
Procedure-related complications 57 2 33 2.5 .76
Deaths 57 2 33 2.5 .26
Hospital stay (days)
Mean 5.4 6.2 .0001
Range 0–90 0–163
Missing data: systemic and procedure-related complications, 3, current.device type at univariate testing. Variables included in this
analysis were type of device, age, male sex, unfitness for
open surgery, team experience, aneurysm diameter, neck
length, and neck diameter. Regression confirmed that,
independent of other factors, current endografts resulted in
a significant reduction in both conversion (hazard ratio
[HR], 0.49; 95% confidence interval [CI], 0.28-0.86; P 
.014) and aneurysm-related death (HR, 0.51; 95% CI,
0.34-0.75; P  .0008). In addition, larger aneurysm or
neck diameter and shorter neck were associated with late
conversion to open repair, and larger aneurysm diameter,
older age, and unfitness for open surgery were predictive of
aneurysm-related death (Table VI).
Influence of changing indications for secondary
intervention on outcome. Although secondary interven-
tions appeared to be required more frequently with with-
drawn devices, this was not necessarily related to endograft
type, because indications for such interventions changed
during the follow-up period. Type II endoleak, in particu-
lar, is now regarded as relatively benign, rarely requiring
more than simple observation. In our groups there was a
small difference in the incidence of late type II endoleak
(8.6% in the withdrawn device group vs 7.6% in the current
device group), but more secondary transfemoral interven-
tions were performed to treat isolated type II endoleak in
patients with withdrawn devices: 34 (2.8%) versus 26
(0.9%). In other terms, 32.4% of all transfemoral interven-
tions in the withdrawn device group and 12.4% in the
current device group were performed to treat isolated type
II endoleak. We therefore performed a further multivariate
analysis that included isolated late type II endoleak and
related secondary transfemoral interventions as covariates
to confirm the potential influence of device type on aneu-
rysm-related death and late conversion to open repair.
This analysis confirmed that treatment with current
devices had a protective effect on both aneurysm-related
death (HR, 0.52; 95% CI, 0.35-0.79; P  .001) and
conversion (HR, 0.47; 95% CI, 0.27-0.82; P  .008).
Conversion was also associated with larger aneurysm diam-
eter (HR, 1.03; 95% CI, 1.01-1.05; P  .0015 for 1-mm
increase above mean) and neck diameter (HR, 1.2; 95% CI,
1.03-1.22; P  .0085 for 1-mm increase above mean).
Aneurysm-related death was also associated with unfitness
for open surgery (HR, 2.25; 95% CI, 1.5-3.3; P  .0001),
older age (HR, 1.09; 95% CI, 1.06-1.2; P  .0001 for
1-year increase above mean), and aneurysm diameter (HR,
1.03; 95% CI, 1.01-1.04; P  .0005 for 1-mm increase
above mean). Of interest, isolated type II endoleak seemed
to have a protective effect on aneurysm-related death (HR,
0.09; 95% CI, 0.02-0.63; P  .016).
DISCUSSION
Our analysis of EUROSTAR data strongly suggests
that the use of current devices has improved midterm
outcome of endovascular repair of abdominal aortic aneu-
rysms, halving the need for secondary transfemoral inter-
vention and significantly reducing conversion to open re-
pair and aneurysm-related death. Although aneurysm
1, lo
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drawn devices, we could not demonstrate a statistically
significant difference, because even in our large database
rupture was reported infrequently in the first 3 years after
Fig 1. Freedom from secondary transfemoral intervent
(dotted line). Difference statistically significant (P .000
Fig 2. Freedom from conversion to open repair with cu
Difference statistically significant (P  .007, log-rank tethe operation. In accord with other reports,4,7 we con-
firmed that larger aneurysm and neck diameter is associated
with poorer results. It is not surprising that older age and
unfitness for open surgery were predictors of aneurysm-
ith current devices (solid line) and withdrawn devices
g-rank test).
devices (solid line) and withdrawn devices (dotted line).ion wrrent
st).
).
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risk of secondary interventions. In contrast with previous
reports from EUROSTAR,4,6 team experience did not have
a significant influence on midterm results. This finding
should be interpreted with caution, because the criteria
used to define team experience in this analysis (60 cases)
were different from those applied in these reports. In par-
ticular, Laheij et al6 divided surgical teams into four quar-
tiles according to previous experience, and showed better
results for teams with the largest number of cases. How-
Fig 3. Freedom from aneurysm-related death with cur
Difference statistically significant (P  .02, log-rank test
Table VI. Factors influencing outcome during follow-up
Hazard
ratio
95%
Confidence
interval P
Conversion to open repair
Current devices 0.49 0.28–0.86 .014
Mid-neck diameter (mm) 1.1 1.01–1.2 .027
Sac diameter (mm) 1.03 1.01–1.05 .015
Neck length (mm) 0.95 0.92–0.98 .0003
Aneurysm-related death
Current devices 0.51 0.34–0.75 .0008
Aneurysm diameter (mm) 1.03 1.01–1.04 .0004
Age (y) 1.09 1.06–1.12 .0001
Unfitness for open surgery 2.08 1.4–3.1 .0004
Hazard ratios for 1-mm increase above mean (aneurysm and sac diameter,
neck length) and 1 year above mean (age).
Factors not associated with conversion: age (P .08), team experience (P
.79), fitness for open surgery (P  .91), male sex (P  .34).
Factors not associated with aneurysm-related death: team experience (P 
.9), mid-neck diameter (P .2), male sex (P .56), neck length (P .17).ever, they did not consider withdrawn devices as a possible
factor, and, as would be expected, such endografts were
used more frequently by inexperienced teams. The current
multivariate analysis therefore suggests that the previously
suspected influence of better team experience on outcome
was largely secondary to the use of current devices, not vice
versa.
The only undesirable outcome, which appeared to oc-
cur more frequently with current devices, was the presence
of type II endoleak on completion of endovascular repair.
This finding could be related to better radiologic equip-
ment in use over the past few years, and increased awareness
of the condition by surgical teams, rather than a real differ-
ence in incidence. It is reassuring that there was a similar
incidence of type I operative endoleak in the 2 study
groups. Whether true or false, a difference in the incidence
of type II endoleak is of little practical importance, inas-
much as this type of endoleak is not associated with in-
creased risk for adverse clinical events.10 Paradoxically,
isolated late type II endoleak was predictive of a better
outcome in our patients.
The importance of aneurysm and neck anatomy high-
lighted by our analysis confirms the findings of recent
studies. Ouriel et al,7 in a cohort of 700 patients undergo-
ing endovascular aneurysm repair, showed that patients
with larger aneurysms (55 mm) were at greater risk for
type I endoleak, device migration, conversion to open
repair, aneurysm-related death, and all-cause death. Alber-
tini et al5 demonstrated that patients with proximal en-
doleaks had wider aneurysm necks compared with those
evices (solid line) and withdrawn devices (dotted line).rent d
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proximal endoleak. Previous data from EUROSTAR had
already suggested that wide neck and large aneurysm were
predictors of conversion to open repair.4 In our study the
influence of aneurysm anatomy appeared to be indepen-
dent of the type of device used. Progressive enlargement of
the infrarenal aortic neck occurs after endovascular re-
pair,11,12 which could lead to graft migration and therefore
aneurysm rupture.9 It is hoped that further developments
in technology, such as graft fenestration,13,14 will address
this problem.
It is also reassuring that the improved clinical outcome
associated with the use of current devices was not depen-
dent on changing indications for secondary intervention. In
particular, it seems likely that a significant proportion of
transfemoral interventions in patients with withdrawn de-
vices and isolated type II endoleak would not be performed
today. However, after adjustment for these confounding
variables, treatment with current endografts still predicted
better outcomes.
With the exception of a small number of EVT en-
dografts (Endovascular Technologies), all withdrawn de-
vices registered with EUROSTAR were either Stentor
(Mintec) or Vanguard (Boston Scientific) endoprostheses.
The 2 devices were based on similar designs, with a nitinol
metal frame outside of a polyester graft, a short body, and
long iliac limbs, and they displayed similar patterns of
failure. These included suture breakage, nitinol wire frac-
ture, a high incidence of graft distortion leading to limb
occlusion, and, in the case of the Vanguard endograft,
separation of the top rows of the nitinol frame. This study
could thus be criticized because it simply addressed the
failure of one particular endograft design rather than im-
provements in technology. Manufacturers have produced
several current endografts with different characteristics, on
the basis that these features led to improved reliability and
clinical outcome. It is, however, possible that better results
are at least in part related to elimination of the structural
faults that marred withdrawn devices. If this hypothesis is
true, it would justify the early withdrawal of the first EVT
devices in 1995 after reports of fractures of the hooks in the
fixation system, and reintroduction of a newly designed
endograft shortly thereafter. Despite these modifications,
withdrawn EVT devices in EUROSTAR were associated
with a high frequency of failure to complete the procedure
(9.8%) and conversion to open repair at 1 (7.8%) and 12
(16%) months. In 1998 the new endograft was introduced,
with an improved delivery system (Ancure; Guidant) and
stronger fixation hooks with less acute angulation and
attachment to the graft body. These changes justified its
inclusion in the current cohort. It is difficult, however, to
draw meaningful conclusions about EVT endografts from
this study, in view of the small number of cases recorded in
EUROSTAR.
Another weakness of our study lies in its design, be-
cause data based on voluntary registries may be subject to
some bias due to selective reporting or may be submitted
only by enthusiastic, and thus more dedicated, surgicalteams. The large number of patients recruited in EURO-
STAR, however, provides a strong basis to support our
findings, and would be impossible to obtain in a similar
time period with other means.
The improvement in outcome seen with current de-
vices appears to be genuinely due to better endograft
design. Endovascular aneurysm repair should therefore be
judged on contemporary data, and caution should be used
when interpreting data from studies that include patients
with withdrawn devices. When necessary, future reports
should take into account the potential influence of device
generation in the analysis.
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